Videos

Clearside Releases Phase II RVO Results

By Mario Admin | December 1, 2016

Dosing of the suprachoroidal space with Zuprata, Clearside Biomedical’s proprietary triamcinolone formulation, can provide high bioavailability of drug to the retina and choroid while avoiding…

Read More

OIS Index Introduced at OIS@AAO

By Mario Admin | November 29, 2016

The OIS Index, a composite of ophthalmic growth stocks, was introduced at OIS@AAO. The purpose of the OIS Index is to provide a tool for…

Read More

NEI Pursues Innovation on Multiple Tracks

By Mario Admin | November 29, 2016

Since a congressional mandate required the National Institutes of Health to set aside 3% of its total funding for small business grants, the National Eye…

Read More

What It Takes to Build an Ophthalmic Franchise

By Mario Admin | November 29, 2016

CHICAGO—Some of the world’s largest ophthalmic companies were represented here during OIS@AAO to discuss what it takes to build a successful ophthalmic franchise. Panel moderator…

Read More

Iconic Leader Allergan Has No Plans to Slow Down

By Michelle Dalton | November 29, 2016

CHICAGO—This year’s OIS Industry Tribute celebrated one of the best-known names in ophthalmology: Allergan. The Dublin-based company is one that “we rely on for innovation…

Read More

How Changes in Physician Payment Can Impact Innovation

By Mario Admin | November 29, 2016

The methodology private and government payers use to measure quality outcomes in health care is changing, David W. Parke II, MD, CEO of the American…

Read More

Masters: Tech Leaders Bring New Insights to R&D

By Mario Admin | November 29, 2016

Ophthalmology remains one of the likeliest targets for technology companies looking to make an impact – and to build a business – within health care.…

Read More

Omega Ophthalmics

By Mario Admin | November 28, 2016

Omega Ophthalmics was founded in 2011 with the intent to bring a new, first in class intraocular lens to market. The lens represents a real…

Read More

McEvoy Discusses J&J’s Renewed Interest in Eye Care

By Mario Admin | November 21, 2016

Ashley McEvoy, company group chairman, Johnson & Johnson Vision, shares why ophthalmology is attractive to J&J and other players. In discussing Abbott Medical Optics, McEvoy…

Read More

Perfect Lens

By Mario Admin | November 21, 2016

Perfect Lens, LLC (“Perfect”), is a company located in Irvine California. Perfect has built the equipment and created a procedure to enable a physician to…

Read More

Omeros Transforming Patient Care through Small-Molecule and Protein Therapeutics

By Mario Admin | November 21, 2016

CHICAGO—A combination of phenylephrine 1% and ketorolac 0.3% injection is “the first and only FDA-approved intraocular product to prevent miosis and to reduce postop ocular…

Read More
notal-vision-1

Notal Helps Foresee Wet AMD

By Mario Admin | November 21, 2016

Quinton Oswald, CEO of Notal Vision, introduced the company’s ForeseeHome diagnostic tool for wet age-related macular degeneration (AMD). The company is looking to move diagnosis…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.